Biopharma Asia

September/October 2016 | Volume 5 Issue 5

---

Challenges in the Development of Continuous Processes for Vaccines

By: Daniel C. Vellom, PhD, Senior Director, Global Technology & Innovation Sanofi Pas...

---

Footprinting our Drugs : Biologics Process Mass Intensity Tool

By: Bonnie Shum, Engineer (DS-MSAT) Kristi Budzinski, Green BioPharma Program ManagerG...

---

Detection and Management of Protein Aggregation during Downstream Processing

By: Danny K. Chou, Pharm.D., Ph.D., President Compassion Biosolution, LLC

---

Approaches for Dissolution Prediction of Tablets made by Continuous Manufacturing Direct C...

By: Pallavi Pawar, Post- Doctoral Associate in the Department of Chemical and Biochemica...

---

Challenges with Measuring Polysorbate levels in Biopharmaceuticals

By: Shiranthi Jayawickreme, Regulatory & Compliance Administrator Duke Cancer Instit...

---

Productivity and Economic Advantages of Coupling Single-Pass Tangential Flow Filtration to...

By: Mark Schofield, Ph.D., Karl Rogler, Xhorxhi Gjoka, Engin Ayturk, Ph.D., and René Gan...

---

Get Merck’s winning combination for Environmental Monitoring in Isolators

Merck Millipore

---